A monthly podcast for lab professionals covering current advancements in science and technology that can impact better patient care.
Your Lab Journey with the Rh System and Weak D
Description: Discover the marvelous world of Rh D system’s complexity and why weak D is clinically relevant with Tony Casina.
About our Speaker: Tony S. Casina, MT(ASCP)SBB has worked in the blood banking industry for over 40 years with much of it in the commercial blood bank reagent manufacturers sector with hospital experience as a medical technologist and blood bank manager. Tony has provided technical support to laboratories throughout the world utilizing Ortho’s reagents and immunohematology test systems. He has tested some of the most challenging antibody problems as part of his reference laboratory experience. Tony has been an active participant in the AABB serving on committees and currently on the AABB Board of Directors. He has contributed as a presenter to AABB and regional blood bank meetings educational programs. He was extensively involved in the development of the ORTHO VISION® Analyzer Platform
The Impact of Innovation in the Health Care System with Dr. Palani Palaniappan
Innovation can refer to something new or to a change made to an existing product, idea, or field. In this episode of Ortho Science Bytes let’s discuss what Innovation means, its importance in the current healthcare ecosystem, and how this concept can impact a Lab's performance.
About our Speaker: Chockalingam “Palani” Palaniappan, chief innovation officer at Ortho Clinical Diagnostics, is responsible for driving a culture of innovation, with a strong focus on enhancing product development productivity and processes. Prior to joining Ortho, Dr. Palani served as chief technology officer at Epic Sciences. Earlier, he was vice president for research and development in the cellular analysis division of Life Technologies Corp., a life sciences company in Eugene, Ore., providing labeling and detection services for DNA, RNA, protein and cells. He also served as head of molecular diagnostics research and development at Amersham Biosciences, a unit of GE Healthcare in Piscataway, N.J. Dr. Palani has served as a board member for Terumo Global Business Management and the State of Oregon Biosciences and Technology Initiatives, OTRADI & ONAMI. He also received the City of Lakewood Mayor’s Inspirational Leadership in Healthcare recognition in 2017. Dr. Palani holds a Ph.D. in biological sciences from Northern Illinois University and was a post-doctoral research fellow with the department of biochemistry and biophysics at the University of Rochester.
The Role of High Throughput Antigen SARS-CoV-2 Testing in a Large, Metropolitan Hospital System
Discuss with the Vice-Chair and Medical Director of Pathology for a large, metropolitan hospital the challenges the lab is facing with the surging number of COVID-19 cases and how a high throughput antigen test has contributed to meeting the demand for more testing. In this podcast episode, we will explore those key points and more.
About our Speaker:Dr. Roush holds several positions within the Methodist Health System in the Dallas, Texas area, including Vice-Chair, Department of Pathology and Medical Director for Pathology, Transfusion Services, and the Transplant Immunology Laboratory. She also serves on several committees across the Methodist Health System. She is the author of several books and book chapters on the topic of blood banking and transfusion medicine in addition to articles that have been published in peer-reviewed journals.
Reading Materials: https://www.mdpi.com/2077-0383/10/2/265
Safety Measures for Blood Products for SARS-CoV-2
There are several measures to ensure safety in blood products, and one of them is Pathogen Reduction Technology (PRT) which is used in some instances by blood banks to help make blood transfusions safer for patients by reducing the pathogen load of a broad range of disease-causing viruses, bacteria, and parasites and help reduce transfusion reactions in patients. With COVID-19 rapidly spreading across the globe, blood banks may consider pathogen reduction technology as an added processing step to help ensure an adequate and safe supply of blood for patients.This Podcast will provide background on the virology of SARS-CoV-2 and PRT, as well as reviewing the scientific evidence supporting the usefulness of safety measures in protecting transfusion patients from this new virus.
About our Speaker:Dr. Raymond P. Goodrich is the Executive Director of the Infectious Disease Research Center and a professor of Immunology and Pathology in the Department of Microbiology at Colorado State University. His research group is currently focused on methods to safeguard blood transfusion products and to create and rapidly produce novel vaccine formulations that can be used to address infectious diseases.
Is Sars-Cov-2 transmitted by blood transfusion?
Can Sars-Cov-2, the virus that causes COVID-19, be transmitted by blood transfusion? In this podcast episode, we will discuss with an Infectious Disease Specialist key points behind the precedent for respiratory viruses, factors to consider in an assessment for a pathogen to cause transfusion-transmitted infection, the data available, and the recommendations to maintain blood safety.
About our Speaker: Written on the promotional piece: Dr. Louis Katz is currently the Chief Medical Officer of Mississippi Valley Regional Blood Center. Dr. Katz is a board-certified internist and infectious diseases specialist who trained at the University of Iowa. He is an Adjunct Clinical Professor of Internal Medicine at the Roy and Lucille Carver College of Medicine, former Chief Medical Officer at America’s Blood Centers in Washington, DC, an ABC past president, former board member, and a past chair of its Scientific, Medical and Technical committee. His transfusion medicine career has been dominated by attention to transfusion-transmitted infections. He has served multiple terms as the chair of the AABB Transfusion Transmitted Diseases Committee and served on many AABB committees and working groups. Dr. Katz is on the Editorial Board of the journal Transfusion, has served on the FDA Blood Products Advisory Committee as a member, industry representative, and chair, and is a current member of the HHS Advisory Committee on Blood and Tissue Safety and Availability. He has been the author of more than sixty peer reviewed publications and book chapters.
The importance of extended antigen typing in Transfusion Medicine
Review the role of extended antigen typing or phenotyping in Transfusion Medicine. How this practice plays a significant role in the transfusion of sickle cell, thalassemia, and myelodysplastic syndrome patients as well as other chronically transfused patients, preventing the development of foreign antibodies which may avoid the challenges that come later with complex antibody problems and brings the additional benefit of allowing finding compatible blood for patients in need of a transfusion. In this podcast edition, we will explore those key points and more.
About our Speaker: Tony S. Casina, MT(ASCP)SBB has worked in the blood banking industry for over 40 years with much of it in the commercial blood bank reagent manufacturers sector with hospital experience as a medical technologist and blood bank manager. Tony has provided technical support to laboratories throughout the world utilizing Ortho’s reagents and immunohematology test systems. He has tested some of the most challenging antibody problems as part of his reference laboratory experience. Tony has been an active participant in the AABB serving on committees and currently on the AABB Board of Directors. He has contributed as a presenter to AABB and regional blood bank meetings educational programs. He was extensively involved in the development of the ORTHO VISION® Analyzer Platform.